Interest in psychedelic-assisted therapies* (PAT) has increased dramatically in the last few years, and for good reason. The evidence suggests that clinical use of Psilocybin (magic mushrooms), MDMA, ...
Co-authored by Azin Dastpak and Robert T. Muller, Ph.D. Neurofeedback has been purported to treat symptoms of attention-deficit/hyperactivity disorder (ADHD), such as ...
This collaboration sets out to explore whether using the Matter Neuroscience protocol combined with real-time neurofeedback can influence emotional brain networks relevant to depression. PALO ALTO, ...